(S)-3-Hydroxy-4-(trimethylammonio)butanoate, 98%, 25g

(E)-3-(5-Bromothiophen-2-yl)acrylic acid, 97%, 1g

(R)-2-(1-Aminoethyl)nicotinonitrile dihydrochloride, 97.0%, 250mg

(1-Methoxycyclopropyl)methanamine hydrochloride, 97%, 5g

Cyclopentane>98.0%(GC)25mL

N-(6-Hydrazinyl-6-oxohexyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 97%, 25mg

tert-Butyl 4-aminoazepane-1-carboxylate, 97.0%, 1g

(R)-3-((tert-Butoxycarbonyl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 1g

Ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate, 95.0%, 2.5g

D-Pipecolic Acid>98.0%(T)5g

Diethyl 2,2-dimethylmalonate, 95.0%, 100g

BioBlue BB.4269 Digital Biocular with 4x/10x/S40x/S60x objectives, with cross table

TERT-BUTYL 4-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-5-YL)PIPERAZINE-1-CARBOXYLATE, 95%, 5g